Synthese von maßgeschneiderten Glycokonjugaten, die AT‐III‐vermittelt die Blutgerinnungsfaktoren Xa und Thrombin inhibieren

This publication has 22 references indexed in Scilit:

• Rational design of synthetic heparin analogues with tailor-made coagulation factor inhibitory activity
  Nature Structural & Molecular Biology, 1995
• Die charakteristische AT‐III‐Bindungsregion in Heparin: eine Leitstruktur für neue synthetische Antithrombotica
  Angewandte Chemie, 1993
• The Unique Antithrombin III Binding Domain of Heparin: A Lead to New Synthetic Antithrombotics
  Angewandte Chemie International Edition in English, 1993
• A Short Synthetic Route towards a Biologically Active Heparin‐like Pentasaccharide with a Pseudo‐Alternating Sequence
  Angewandte Chemie International Edition in English, 1993
• Kurze Synthese eines biologisch aktiven, Heparin-ähnlichen Pentasaccharids mit pseudo-alternierender Sequenz
  Angewandte Chemie, 1993
• Biologically active heparin-like fragments with a “non-glycosamino”glycan structure. Part 3 : o-alkylated-o-sulphated pentasaccharides.
  Bioorganic & Medicinal Chemistry Letters, 1992
• Constructing a molecular model of the interaction between antithrombin III and a potent heparin analog
  Journal of the American Chemical Society, 1991
• New Methods for the Synthesis of Glycosides and Oligosaccharides—Are There Alternatives to the Koenigs‐Knorr Method? [New Synthetic Methods (56)]
  Angewandte Chemie International Edition in English, 1986
• Structure-activity relationship in heparin: A synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity
  Biochemical and Biophysical Research Communications, 1983
• STRUCTURAL STUDIES ON A BIOLOGICALLY ACTIVE HEXASACCHARIDE OBTAINED FROM HEPARIN
  Annals of the New York Academy of Sciences, 1981